摘要
目的:观察阿奇霉素-罗红霉素序贯疗法治疗儿童社区获得性肺炎(CAP)的疗效。方法:64例患儿随机分为治疗组和对照组。治疗组予阿奇霉素-罗红霉素序贯治疗,对照组予头孢噻肟-头孢克洛序贯治疗,观察两组疗效。结果:治疗组和对照组总有效率分别为96.97%、77.42%,两组比较差异有统计学意义(χ2=6.48,P<0.05)。结论:阿奇霉素-罗红霉素序贯疗法治疗儿童轻、中度社区获得性肺炎疗效显著,能减少院内交叉感染,减少穿刺局部反应,节约医疗资源,可推广应用。
Objective： To observe the clinical efficacy of azithromycin-roxithromycin for sequential therapy of community acquired pneumonia in children. Methods： 64 children with community acquired pneumonia were randomly divided into two groups： the treatment group and the control group. Thirty-three cases in treatment group were treated with azithromyein-roxithromcin, thirty-one cases in control group were treated with cefotaxime-cefaclor. Then the therapeutic effects were evaluated. Results： The total effective rates of treatment group and control group were 96.97% and 77.42%,respectively. The effective rate was higher in treatment group than in control group （X^2 = 6.48, P 〈 0.05）. Conclusions： The treatment of azithromycin-roxithromycin for sequential therapy of unsefious community acquired pneumonia in children is very useful, which reduces both the cross infections in hospital and response of the puncture point. This treatment decreases the cost of medicine resource. It is valuable to apply widely.
出处
《儿科药学杂志》
CAS
2006年第1期15-16,共2页
Journal of Pediatric Pharmacy
